The prognostic value of residual nodal disease following neoadjuvant chemoradiation for esophageal cancer in patients with complete primary tumor response-Reference-Cited by-同舟云学术

The prognostic value of residual nodal disease following neoadjuvant chemoradiation for esophageal cancer in patients with complete primary tumor response

Published:2015-09-23 Issue:6 Volume:112 Page:597-602
ISSN:0022-4790
Container-title:Journal of Surgical Oncology
language:en
Short-container-title:J. Surg. Oncol.

Author:

Blackham Aaron U.¹,Yue Binglin²,Almhanna Khaldoun¹,Saeed Nadia¹,Fontaine Jacques P.¹,Hoffe Sarah³,Shridhar Ravi³,Frakes Jessica³,Coppola Domenico⁴⁵⁶,Pimiento Jose M.¹

Affiliation:

1. Department of Gastrointestinal Oncology; Moffitt Cancer Center and Research Institute; Tampa Florida

2. Department of Biostatistics; Moffitt Cancer Center and Research Institute; Tampa Florida

3. Department of Radiation Oncology; Moffitt Cancer Center and Research Institute; Tampa Florida

4. Department of Anatomic Pathology; Moffitt Cancer Center and Research Institute; Tampa Florida

5. Department of Tumor Biology; Moffitt Cancer Center and Research Institute; Tampa Florida

6. Program of Chemical Biology & Molecular Medicine; Moffitt Cancer Center and Research Institute; Tampa Florida

Publisher

Wiley

Subject

Oncology,General Medicine,Surgery

Reference30 articles.

1. Pathologic response after neoadjuvant therapy is the major determinant of survival in patients with esophageal cancer;Meredith;Ann Surg Oncol,2010

2. Preoperative chemoradiotherapy for esophageal or junctional cancer;van Hagen;New Engl J Med,2012

3. Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781;Tepper;J Clin Oncol,2008

4. Improved long-term outcome with chemoradiotherapy strategies in esophageal cancer;Swisher;Ann Thorac Surg,2010

5. Characterization of pathologic complete response after preoperative chemoradiotherapy in carcinoma of the esophagus and outcome after pathologic complete response;Rohatgi;Cancer,2005

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integration of genomic aberrations to predict clinical outcomes for patients with gastroesophageal adenocarcinoma receiving neoadjuvant chemotherapy;ESMO Gastrointestinal Oncology;2024-03

2. Extensive lymphadenectomy may improve survival in node negative oesophageal cancer;Scientific Reports;2024-02-01

3. Oncologic Outcome of Patients With Pathologic T0 Esophageal Squamous Cell Carcinoma After Neoadjuvant Chemoradiotherapy;Cancer Control;2024-01

4. Prognostic role of pathologic status other than complete response after neoadjuvant therapy followed by surgery in esophageal squamous cell carcinoma;Esophagus;2023-12-12

5. Incidence and management of esophageal cancer recurrence to regional lymph nodes after curative esophagectomy;International Journal of Cancer;2023-01-05